Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.135
+0.115 (3.81%)
Aug 26, 2025, 12:52 PM - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $537.88 million as of August 26, 2025. Its market cap has increased by 287.06% in one year.
Market Cap
537.88M
Enterprise Value
427.10M
1-Year Change
287.06%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $537.88M, an increase of 23.55%. That is a compound annual growth rate of 4.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 518.15M | 159.72% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |